Literature DB >> 15113886

Requirement for integrase during reverse transcription of human immunodeficiency virus type 1 and the effect of cysteine mutations of integrase on its interactions with reverse transcriptase.

Kai Zhu1, Charles Dobard, Samson A Chow.   

Abstract

Retroviral integrase catalyzes the essential step of integrating a double-stranded DNA copy of the viral genome into a host cell chromosome. Mutational studies have revealed that integrase is involved in additional steps of viral replication, but the mechanism for the pleiotropic effect is not well characterized. Since Cys residues generally play crucial roles in protein structure and function, we introduced Cys-to-Ser substitutions at positions 56, 65, and 130 of human immunodeficiency virus type 1 (HIV-1) integrase to determine their effects on integration activity and viral replication. None of the substitutions significantly affected the enzymatic activities in vitro. When introduced into the NL4-3 molecular clone of HIV-1, mutant viruses encoding Cys mutations at positions 56 and 65 of integrase replicated similarly to the wild-type virus in CD4(+)-T-cell lines, whereas the C130S-containing virus was noninfectious. The entry and postintegration steps of the viral life cycle for all mutant viruses were normal, and all had particle-associated reverse transcriptase (RT) activity. However, early reverse-transcribed DNA products were absent in the lysate of cells infected with the C130S mutant virus, indicating that the mutation abolished the ability of the virus to initiate endogenous reverse transcription. Coimmunoprecipitation using purified integrase and RT showed that the C-terminal domain of wild-type HIV-1 integrase interacted with RT. The interaction between integrase and RT was not affected in the presence of a reducing or alkylating agent, suggesting that the interaction did not involve a disulfide linkage. The C130S substitution within the core region may disrupt the protein recognition interface of the C-terminal domain and abolish its ability to interact with RT. Our results indicate that integrase plays an important role during the reverse-transcription step of the viral life cycle, possibly through physical interactions with RT.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15113886      PMCID: PMC400327          DOI: 10.1128/jvi.78.10.5045-5055.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  59 in total

1.  Ty3 integrase is required for initiation of reverse transcription.

Authors:  M Henrietta Nymark-McMahon; Nadejda S Beliakova-Bethell; Jean-Luc Darlix; Stuart F J Le Grice; Suzanne B Sandmeyer
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

2.  Identification of conserved amino acid residues critical for human immunodeficiency virus type 1 integrase function in vitro.

Authors:  A Engelman; R Craigie
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

3.  Structural implications of spectroscopic characterization of a putative zinc finger peptide from HIV-1 integrase.

Authors:  C J Burke; G Sanyal; M W Bruner; J A Ryan; R L LaFemina; H L Robbins; A S Zeft; C R Middaugh; M G Cordingley
Journal:  J Biol Chem       Date:  1992-05-15       Impact factor: 5.157

4.  Characterization of HIV replication complexes early after cell-to-cell infection.

Authors:  L Karageorgos; P Li; C Burrell
Journal:  AIDS Res Hum Retroviruses       Date:  1993-09       Impact factor: 2.205

5.  Murine leukemia virus pol gene products: analysis with antisera generated against reverse transcriptase and endonuclease fusion proteins expressed in Escherichia coli.

Authors:  S C Hu; D L Court; M Zweig; J G Levin
Journal:  J Virol       Date:  1986-10       Impact factor: 5.103

6.  The core and carboxyl-terminal domains of the integrase protein of human immunodeficiency virus type 1 each contribute to nonspecific DNA binding.

Authors:  A Engelman; A B Hickman; R Craigie
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

7.  Human immunodeficiency virus type 1 integrase: effect on viral replication of mutations at highly conserved residues.

Authors:  P M Cannon; W Wilson; E Byles; S M Kingsman; A J Kingsman
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

8.  Genetic analysis of the human immunodeficiency virus type 1 integrase protein.

Authors:  C G Shin; B Taddeo; W A Haseltine; C M Farnet
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

9.  Identification of the catalytic and DNA-binding region of the human immunodeficiency virus type I integrase protein.

Authors:  C Vink; A M Oude Groeneger; R H Plasterk
Journal:  Nucleic Acids Res       Date:  1993-03-25       Impact factor: 16.971

10.  Characterization of human immunodeficiency virus type 1 integrase expressed in Escherichia coli and analysis of variants with amino-terminal mutations.

Authors:  K A Vincent; V Ellison; S A Chow; P O Brown
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

View more
  80 in total

1.  Mechanisms and inhibition of HIV integration.

Authors:  Christophe Marchand; Allison A Johnson; Elena Semenova; Yves Pommier
Journal:  Drug Discov Today Dis Mech       Date:  2006-07-01

2.  A new functional role of HIV-1 integrase during uncoating of the viral core.

Authors:  Marisa S Briones; Samson A Chow
Journal:  Immunol Res       Date:  2010-12       Impact factor: 2.829

3.  Correlation of recombinant integrase activity and functional preintegration complex formation during acute infection by replication-defective integrase mutant human immunodeficiency virus.

Authors:  Xiang Li; Yasuhiro Koh; Alan Engelman
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

4.  Revealing domain structure through linker-scanning analysis of the murine leukemia virus (MuLV) RNase H and MuLV and human immunodeficiency virus type 1 integrase proteins.

Authors:  Jennifer Puglia; Tan Wang; Christine Smith-Snyder; Marie Cote; Michael Scher; Joelle N Pelletier; Sinu John; Colleen B Jonsson; Monica J Roth
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

5.  Interaction between Reverse Transcriptase and Integrase Is Required for Reverse Transcription during HIV-1 Replication.

Authors:  Shewit S Tekeste; Thomas A Wilkinson; Ethan M Weiner; Xiaowen Xu; Jennifer T Miller; Stuart F J Le Grice; Robert T Clubb; Samson A Chow
Journal:  J Virol       Date:  2015-09-23       Impact factor: 5.103

6.  Domain structure and three-dimensional model of a group II intron-encoded reverse transcriptase.

Authors:  Forrest J H Blocker; Georg Mohr; Lori H Conlan; Li Qi; Marlene Belfort; Alan M Lambowitz
Journal:  RNA       Date:  2004-12-01       Impact factor: 4.942

7.  Discovery of a small-molecule HIV-1 integrase inhibitor-binding site.

Authors:  Laith Q Al-Mawsawi; Valery Fikkert; Raveendra Dayam; Myriam Witvrouw; Terrence R Burke; Christoph H Borchers; Nouri Neamati
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-19       Impact factor: 11.205

8.  The self primer of the long terminal repeat retrotransposon Tf1 is not removed during reverse transcription.

Authors:  Angela Atwood-Moore; Kenneth Yan; Robert L Judson; Henry L Levin
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

9.  HIV-1 integrase is capable of targeting DNA to the nucleus via an importin alpha/beta-dependent mechanism.

Authors:  Anna C Hearps; David A Jans
Journal:  Biochem J       Date:  2006-09-15       Impact factor: 3.857

10.  Discovery of small-molecule HIV-1 fusion and integrase inhibitors oleuropein and hydroxytyrosol: part II. integrase inhibition.

Authors:  Sylvia Lee-Huang; Philip Lin Huang; Dawei Zhang; Jae Wook Lee; Ju Bao; Yongtao Sun; Young-Tae Chang; John Zhang; Paul Lee Huang
Journal:  Biochem Biophys Res Commun       Date:  2007-01-22       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.